Treatment of fibrocystic mastopathy with danazol (100mg/day) studied by thermo-echo-clinical examination
Dambrosio, F.; Dibisceglia, G.; Colombo, A.
Annali di Ostetricia Ginecologia Medicina Perinatale Spec No: 44-57
1989
ISSN/ISBN: 0300-0087 PMID: 2672980 Document Number: 327877
Document emailed within 1 workday
Related Documents
Ablanedo, J.; Canales, E.S. 1988: Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy Archivos de Investigacion Medica 19(3): 225-229Luisi, M. 1971: Liver-protective treatment of mammary adenosis and fibrocystic mastopathy Minerva Ginecologica 23(17): 695-698
Radivojevic, K. 1991: Danazol in treatment of cystic mastopathy Wiener Klinische Wochenschrift 103(23): 710-713
Samoĭlova, T.E. 1986: Current concepts of fibrocystic mastopathy Akusherstvo i Ginekologiia 1986(2): 3-6
Schauer, K. 1989: Fibrocystic mastopathy as a cancer risk Zentralblatt für Chirurgie 114(1): 11-17; Discussion: 18-19
Beyrouti, M.I.; Beyrouti, R.; Khabir, A.; Ben Amar, M.; Frikha, F.; Dhieb, N.; Damak, D.; Abid, M.; Affes, N.; Boujelben, S.; Frikha, M. 2006: Fibrocystic mastopathy and cancer of the breast. about 111 cases La Tunisie Medicale 84(10): 626-631
Gorins, A.; Perret, F.; Tournant, B.; Rogier, C.; Lipszyc, J. 1984: A French double-blind crossover study (danazol versus placebo) in the treatment of severe fibrocystic breast disease European Journal of Gynaecological Oncology 5(2): 85-89
Guski, H. 1991: Fibrocystic mastopathy and risk of cancer from the viewpoint of the pathologist Zeitschrift für Arztliche Fortbildung 85(20): 970-972
Serov, V.N.; Tumilovich, L.G.; Rozhkova, N.I.; Samoĭlova, T.E. 1988: The steroid and peptide hormone content of the blood in women with different forms of fibrocystic mastopathy Akusherstvo i Ginekologiia 3: 54-56
1981: Danazol for fibrocystic disease of the breast Medical Letter on Drugs and Therapeutics 23(2): 5-6
Sakhautdinov, V.G.; Nigmatullin, R.A.; Makar'eva, N.M.; Vasil'eva, T.V.; Usatova, O.S. 1997: Echo-, thermo- and rheographic assessments of the mammoplasty results using an allograft in patients with suppurative mastitis Vestnik Khirurgii Imeni I. I. Grekova 156(3): 61-63
Macor, F.; Bongiovì, S.; Martina, S.; Pessina, A.C.; Palatini, P. 1991: Left ventricular filling studied by echo-Doppler in hypertensive and normotensive subjects Giornale Italiano di Cardiologia 21(2): 151-161
Kociałkowski, K.; Otworowski, A. 1992: Cystectomy accompanied by immediate examination as the preferred method of treating fibrocystic breast disease Ginekologia Polska 63(1): 26-27
Rannevik, G. 1979: Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis Postgraduate Medical Journal 55(Suppl 5): 14-20
Ju, X.; Chu, L.; Li, Y. 2004: Study on thermo-sensitive intelligent targeting type drug carriers (I) porous membranes with grafted thermo-sensitive gates Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21(5): 791-794
Gambashidze, K.G.; Kalandarishvili, K.G.; Khorava, P.A.; Azaladze, T.N.; Lasareishvili, B.G.; Dzhaiani, E.G.; Tediashvili, M.I. 2012: Application of bacterial thermo- and phagelysates for suppression of malignant tumor growth in experimental studies: 2 comparative analysis of anticancer efficacy of thermo- and phagelysates of Ps. aeruginosa and E. coli Georgian Medical News 207: 50-56
Gorins, A.; Kottler, M.L. 1991: What is mastopathy at risk? Epidemiologic and clinical basis Revue Francaise de Gynecologie et d'Obstetrique 86(1): 4-8
Engeler, V.; Schreiner, W.E. 1977: Surgical treatment for mastopathy Schweizerische Rundschau für Medizin Praxis 66(17): 517-520
D'Angelo, E.; Aulisio, G.A. 1970: Fibrocystic dysplasia of the parotid gland (clinical contribution) La Clinica Otorinolaringoiatrica 22(5): 315-328
Perricone, G.; Luppis, F.; Escalante Moreno, J.C. 1979: Comparative studies of clinical examination, electrical examination, and electromyography (EMG) in 30 patients suffering from lumbar backache (EMG examination of the paravertebral muscles) La Chirurgia Degli Organi di Movimento 65(1): 35-41